These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 14977487)
21. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets. Holmøy T Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322 [TBL] [Abstract][Full Text] [Related]
22. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688 [TBL] [Abstract][Full Text] [Related]
23. More to come: humoral immune responses in MS. Dobson R; Meier UC; Giovannoni G J Neuroimmunol; 2011 Dec; 240-241():13-21. PubMed ID: 22019113 [TBL] [Abstract][Full Text] [Related]
24. Novel approaches and cutting edge immunotherapies in multiple sclerosis. Bauman TM; Kasper LH Front Biosci; 2004 Sep; 9():2302-22. PubMed ID: 15353289 [TBL] [Abstract][Full Text] [Related]
25. Immunopathogenesis of multiple sclerosis: concepts and controversies. Holmøy T Acta Neurol Scand Suppl; 2007; 187():39-45. PubMed ID: 17419827 [TBL] [Abstract][Full Text] [Related]
26. Multiple Sclerosis: New Aspects of Immunopathogenesis. Lazibat I; Rubinić Majdak M; Županić S Acta Clin Croat; 2018 Jun; 57(2):352-361. PubMed ID: 30431730 [TBL] [Abstract][Full Text] [Related]
30. [Recent prognosis on etiology and pathophysiology of multiple sclerosis]. Niino M Nihon Rinsho; 2013 May; 71(5):807-10. PubMed ID: 23777086 [TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis and central nervous system demyelination. Pouly S; Antel JP J Autoimmun; 1999 Nov; 13(3):297-306. PubMed ID: 10550217 [TBL] [Abstract][Full Text] [Related]
32. Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients. Kuerten S; Lanz TV; Lingampalli N; Lahey LJ; Kleinschnitz C; Mäurer M; Schroeter M; Braune S; Ziemssen T; Ho PP; Robinson WH; Steinman L Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21512-21518. PubMed ID: 32817492 [TBL] [Abstract][Full Text] [Related]
33. The good and the bad of neuroinflammation in multiple sclerosis. Naegele M; Martin R Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513 [TBL] [Abstract][Full Text] [Related]
34. B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence. Kinzel S; Weber MS CNS Drugs; 2016 Dec; 30(12):1137-1148. PubMed ID: 27844213 [TBL] [Abstract][Full Text] [Related]
35. The role of B cells in the immunopathogenesis of multiple sclerosis. Gharibi T; Babaloo Z; Hosseini A; Marofi F; Ebrahimi-Kalan A; Jahandideh S; Baradaran B Immunology; 2020 Aug; 160(4):325-335. PubMed ID: 32249925 [TBL] [Abstract][Full Text] [Related]
36. The essential role of T cells in multiple sclerosis: a reappraisal. Constantinescu CS; Gran B Biomed J; 2014; 37(2):34-40. PubMed ID: 24732657 [TBL] [Abstract][Full Text] [Related]
37. B cells: no longer the nondominant arm of multiple sclerosis. Klawiter EC; Cross AH Curr Neurol Neurosci Rep; 2007 May; 7(3):231-8. PubMed ID: 17488589 [TBL] [Abstract][Full Text] [Related]
38. The role of dendritic cells in multiple sclerosis. Wu GF; Laufer TM Curr Neurol Neurosci Rep; 2007 May; 7(3):245-52. PubMed ID: 17488591 [TBL] [Abstract][Full Text] [Related]